Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials

Autor:	Grebely, Jason, Mauss, Stefan, Brown, Ashley, Bronowicki, Jean-Pierre, Puoti, Massimo, Wyles, David, Natha, Macky, Zhu, Yanni, Yang, Junming, Kreter, Bruce, Brainard, Diana M., Yun, Chohee, Carr, Val, Dore, Gregory J.
Zdroj:	Clinical Infectious Diseases, 2016 Dec 01. 63(11), 1405-1411.
Databáze:	JSTOR Journals
Externí odkaz:	https://www.jstor.org/stable/26373377 Zobrazit plný text záznamu